Tirzepatide is a prescription drug that requires refrigeration. If it has been stored at room temperature for longer than the permitted time indicated in the instructions (usually refrigerated at 2-8℃ when unopened, and no more than 21-28 days at room temperature after opening), it is not recommended to continue using it. Specific advice should be given according to the drug's instructions or a doctor's guidance. If storage conditions are not met, the drug may become ineffective or deteriorate, posing a safety hazard.
Tirzepatide belongs to the GLP-1 receptor agonist class of drugs, most of which require strict refrigeration (2-8℃). Once opened, room temperature storage usually has a specified time limit (e.g., 21 days). If it has been stored at room temperature for 6 days within the permitted range and the temperature has not exceeded 30℃, it can be used normally; if the permitted time has been exceeded or the storage temperature is too high, it should be discarded.
Drug Inactivation Risk: Exceeding the permitted temperature or prolonged storage may cause denaturation of the drug's protein structure and degradation of the active ingredient, affecting its efficacy. Even if there is no change in appearance, it may still fail to achieve the expected blood sugar control or weight loss effects, and may even cause adverse reactions.
Safety Handling Recommendations:
**Immediate Discontinue Use:** If you are unsure whether the storage conditions meet the requirements, or if the storage time has exceeded the instructions, you should stop using the medication.
**Consult a Doctor or Pharmacist:** Based on your current medication needs, determine if a new medication is needed, and check if the medication you are currently using is causing any discomfort.
**Proper Disposal:** Dispose of the medication as medical waste to avoid environmental pollution or misuse.